CTOs on the Move

ICANotes

www.icanotes.com

 
ICANotes is a Asbury, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Bronson Healthcare

With nearly 8,500 employees, more than 1,500 medical staff members, and 837 licensed beds, Bronson Healthcare is the largest employer and leading healthcare system in southwest Michigan. It offers a full range of services from primary care to critical care across more than 100 locations. Key member organizations include: Bronson Methodist Hospital, Bronson Battle Creek, Bronson LakeView Hospital, Bronson South Haven Hospital, Bronson Medical Group, Bronson at Home, Bronson Commons, Bronson Athletic Club, Bronson Wellness Center and the Bronson Health Foundation.

Custom Granular

Custom Granular is a Genoa City, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ranch Terrace Nursing Home Inc

Ranch Terrace Nursing Home Inc is a Sapulpa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health IQ

At Health IQ, we believe the best way to improve the health of the world is to celebrate the health conscious rather than harassing those who are not.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.